NASDAQ, NUVA - Nuvasive Inc
We are a medical device company focused on the design, development and marketing
of products for the surgical treatment of spine disorders. Our
currently-marketed product portfolio is focused on applications for spine fusion
surgery, a market estimated to exceed $4.2 billion in the United States in 2008.
Our principal product offering includes a minimally disruptive surgical platform
called Maximum Access Surgery, or MAStm, as well as a growing offering of
cervical and motion preservation products. Our currently-marketed products are
used predominantly in spine fusion surgeries, both to enable access to the spine
and to perform restorative and fusion procedures. ...
Read SEC Filing on NASDAQ.com »